Absence of R140Q mutation of isocitrate dehydrogenase 2 in gliomas and breast cancers
Open Access
- 1 September 2010
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 1 (5) , 883-884
Abstract
Somatic mutations of isocitrate dehydrogenase (IDH)-1 and IDH2 proteins have been described in gliomas. The mutations target the R132 amino acid residue and the R172 residue in IDH1 and IDH2, respectively. The same mutations were observed in acute myeloid leukemias with normal karyotype, but a new mutation in IDH2 (R140Q substitution) was detected in malignant myeloid diseases and appears to be the most frequent IDH mutation in these pathologies. To the best of our knowledge, no study thus far has reported the presence of this R140Q mutation in IDH2 in tumors of the nervous system and breast cancers. We evaluated IDH1 and IDH2 exon 4 in 48 low-grade gliomas, 58 primary glioblastomas and 94 breast cancers to evaluate the frequency of mutation and investigated the R140Q substitution in IDH2. The results were compared to our recently obtained results in hematopoietic diseases. The frequency of IDH1 and IDH2 mutations in our panel of gliomas was similar to previously reported mutations. No IDH2 R140 mutation was observed. Compared to hematopoietic diseases, the IDH2 R172 mutation was also more rare and IDH1 mutations more prominent in tumors of the nervous system. No IDH1 or IDH2 mutation was detected in the 94 breast cancer samples. Thus, the IDH2 R140 mutation appears to be restricted to hematopoietic diseases.Keywords
This publication has 10 references indexed in Scilit:
- The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-HydroxyglutarateCancer Cell, 2010
- Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutationsJournal of Experimental Medicine, 2010
- Somatic Mutations ofIDH1andIDH2in the Leukemic Transformation of Myeloproliferative NeoplasmsNew England Journal of Medicine, 2010
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarateNature, 2009
- Genetic alterations and signaling pathways in the evolution of gliomasCancer Science, 2009
- Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia GenomeNew England Journal of Medicine, 2009
- Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomasActa Neuropathologica, 2009
- Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancersInternational Journal of Cancer, 2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- IDH1mutations at residue p.R132 (IDH1R132) occur frequently in high-grade gliomas but not in other solid tumorsHuman Mutation, 2008